Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Headache|April 21, 2007
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapyStephen D Silberstein, David Dodick, Fred Freitag, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
Canadian Headache Society Guideline: acute drug therapy for migraine headacheIrene Worthington, Tamara Pringsheim, Marek J Gawel, et al.Headache|November 22, 2021
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world studyJonathan Gladstone, Sameer Chhibber, Jagdeep Minhas, et al.The Lancet. Neurology|June 9, 2019
Pathophysiology, prevention, and treatment of medication overuse headacheHans-Christoph Diener, David Dodick, Stefan Evers, et al.Neurology|November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.Cephalalgia : an International Journal of Headache|September 26, 2019
CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in miceEdita Navratilova, Jill Rau, Janice Oyarzo, et al.Cephalalgia : an International Journal of Headache|October 27, 2010
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID studyRichard B Lipton, Stephen Silberstein, David Dodick, et al.Journal of Medical Economics|March 25, 2018
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspectiveRichard B Lipton, Alan Brennan, Stephen Palmer, et al.Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.Headache|September 2, 2009
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measuresStephen Silberstein, Richard Lipton, David Dodick, et al.Pageof 7